Should governments fund research into medicinal plant compounds for treating mental health?

Recent biomedical breakthroughs, including Penn's development of bioengineered compounds from natural sources, highlight growing scientific interest in plant-based treatments. Many countries are reconsidering policies around traditional medicinal plants as mental health crises intensify globally. This raises questions about research priorities and resource allocation.